• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Prevention of Progression in Chronic Liver Disease: An Update on Snmc (Stronger Neo-Minophagen C). in Honour of Hans Popper's 100th Birthday

Prevention of Progression in Chronic Liver Disease: An Update on Snmc (Stronger Neo-Minophagen C). in Honour of Hans Popper's 100th Birthday

Hardcover

Series: Falk Symposium, Book 138

Medical ReferenceBiology

ISBN10: 0792387961
ISBN13: 9780792387961
Publisher: Springer Nature
Published: Jul 21 2004
Pages: 130
Weight: 0.83
Height: 0.38 Width: 6.14 Depth: 9.21
Language: English

In several liver diseases, the underlying cause cannot always be eliminated, i.e. the progression of liver disease cannot be prevented. This is particularly true for non-responders to the treatment of chronic hepatitis C (HCV). It is relevant for more than 40% of patients with HCV genotype 1 and up to 20% of patients with genotype 2 or 3. Several approaches are now underway to prevent or ameliorate mechanisms of disease progression. In Asia, and particularly in Japan, Glycyrrhizine-SNMC has been widely used for this purpose. At present, SNMC is under clinical evaluation in Europe.

Also in

Medical Reference